Page last updated: 2024-10-31

mianserin and Cocaine-Related Disorders

mianserin has been researched along with Cocaine-Related Disorders in 4 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Cocaine-Related Disorders: Disorders related or resulting from use of cocaine.

Research Excerpts

ExcerptRelevanceReference
"Prior findings concerning the use of mirtazapine in the treatment of a variety of substance use disorders and its antagonistic actions at the serotonin 5-HT(2A) receptor suggest that this drug may have efficacy in the treatment of cocaine dependence in the presence of a depressive disorder."5.16The efficacy of mirtazapine in the treatment of cocaine dependence with comorbid depression. ( Afshar, M; Ciraulo, DA; Colaneri, LS; Devine, E; Knapp, CM; Putnam, MA; Sarid-Segal, O; Tozier, L; Waters, ME, 2012)
"Cocaine abuse and dependence are a global public health problem."3.85Synergistic interactions between mirtazapine and prazosin prevent the induction and expression of behavioral sensitization to cocaine in rats. ( Barbosa-Méndez, S; Matus-Ortega, M; Salazar-Juárez, A, 2017)
"Mirtazapine is an antidepressant implicated in reducing behavioral alterations induced by drugs of abuse."1.46Dose- and time-dependent effects of mirtazapine on the expression of cocaine-induced behavioral sensitization in rats. ( Barbosa-Méndez, S; Flores-Zamora, A; Jurado, N; Matus-Ortega, M; Salazar-Juárez, A, 2017)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barbosa-Méndez, S2
Matus-Ortega, M2
Flores-Zamora, A1
Jurado, N1
Salazar-Juárez, A2
Afshar, M1
Knapp, CM1
Sarid-Segal, O1
Devine, E1
Colaneri, LS1
Tozier, L1
Waters, ME1
Putnam, MA1
Ciraulo, DA1
Fisfalen, ME1
Hsiung, RC1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Phase II Clinical Studies on Anti-addictive Therapeutic Effects of Mirtazapine in Human Subjects Addicted to Cocaine.[NCT01949571]Phase 264 participants (Actual)Interventional2007-01-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for mianserin and Cocaine-Related Disorders

ArticleYear
The efficacy of mirtazapine in the treatment of cocaine dependence with comorbid depression.
    The American journal of drug and alcohol abuse, 2012, Volume: 38, Issue:2

    Topics: Adult; Antidepressive Agents, Tricyclic; Cocaine; Cocaine-Related Disorders; Depressive Disorder; Do

2012

Other Studies

3 other studies available for mianserin and Cocaine-Related Disorders

ArticleYear
Dose- and time-dependent effects of mirtazapine on the expression of cocaine-induced behavioral sensitization in rats.
    Psychiatry research, 2017, Volume: 254

    Topics: Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Cocaine; Cocaine-Related Disorders; Dos

2017
Synergistic interactions between mirtazapine and prazosin prevent the induction and expression of behavioral sensitization to cocaine in rats.
    Physiology & behavior, 2017, Oct-15, Volume: 180

    Topics: Adrenergic alpha-1 Receptor Antagonists; Analysis of Variance; Anesthetics, Local; Animals; Cocaine;

2017
Glucose dysregulation and mirtazapine-induced weight gain.
    The American journal of psychiatry, 2003, Volume: 160, Issue:4

    Topics: Adult; Antidepressive Agents, Tricyclic; Blood Glucose; Body Mass Index; Cocaine-Related Disorders;

2003